Sign In
Buy GILD
$125.16
+0.110 (+0.0880%)
At Close: Jun 24, 2026
Gilead Sciences (GILD) Beats Stock Market Upswing: What Investors Need to Know
07:01pm, Tuesday, 16'th Jul 2024
In the closing of the recent trading day, Gilead Sciences (GILD) stood at $71.64, denoting a +1.17% change from the preceding trading day.
Gilead to Highlight Landmark Progress in Research Across HIV Prevention, Treatment and Cure Programs at AIDS 2024
08:30am, Tuesday, 16'th Jul 2024
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced its program for the upcoming 25th International AIDS Conference (AIDS 2024), taking place in Munich, Germany,
The 3 Most Undervalued Nasdaq 100 Stocks to Buy in July 2024
10:51am, Monday, 15'th Jul 2024
As good as the S&P 500 is performing in 2024, the Nasdaq 100 is doing even better. The tech-oriented index is up 23% this year, compared to an 19% gain by the benchmark index.
3 Dividend Growth Stocks to Buy and Hold
06:30am, Sunday, 14'th Jul 2024
AbbVie is poised to keep a 52-year streak of dividend hikes going. Amgen offers more than a dividend with its promising pipeline.
The 7 Most Undervalued Healthcare Stocks to Buy in July 2024
11:00am, Saturday, 13'th Jul 2024
Over the years, especially the past three, I have become more cautious about the technology sector's blatant overvaluation. Nevertheless, it is difficult to ignore the capabilities of companies such a
3 Underappreciated Stocks About to Break Their Chains
10:30am, Thursday, 11'th Jul 2024
As investors buy from tech giants like Nvidia, many other compelling opportunities exist for those looking for growth. Driven by innovation, revenue growth, and an enviable market position, each of th
Why Gilead Sciences (GILD) Outpaced the Stock Market Today
07:05pm, Wednesday, 10'th Jul 2024
The latest trading day saw Gilead Sciences (GILD) settling at $68.75, representing a +1.46% change from its previous close.
7 Cheap Biotech Stocks With Major Upside Potential
06:00am, Tuesday, 09'th Jul 2024
Intuitively, the case for biotechnology-related investments comes across rather obviously: the concept of healthcare should be a permanent one. And because of this permanence, the expected market valu
Gilead Gets Analyst Upgrade on 'Outstanding' HIV Treatment Data
01:06pm, Monday, 08'th Jul 2024
Gilead Sciences (GILD) shares climbed in intraday trading Monday after Raymond James analysts upgraded the drug developer to “outperform” from “market perform.”
Gilead (GILD) Loses 17.6% YTD: How Should You Play the Stock?
10:10am, Monday, 08'th Jul 2024
While Gilead (GILD) has been reeling under pressure year to date due to pipeline setbacks, holding on to this biotech giant will be prudent at current levels.
Analyst: Science Stock Sports Long-Term Support
09:20am, Monday, 08'th Jul 2024
Shares of drugmaker Gilead Sciences, Inc. (NASDAQ:GILD) are up 2% in pre-market trading, after Raymond James upgraded the stock to "outperform" from "market perform.
Going Beyond Morningstar's 10 Best Value Stocks List
11:57pm, Monday, 01'st Jul 2024
Morningstar published 10 Best Value Stocks to Buy for the Long Term, undervalued blue-chip stocks with low price to fair value. Valuation and future return of each stock analyzed, compared to the S&P
3 Magnificent Stocks Retirees Can Buy and Hold Forever
06:50am, Monday, 01'st Jul 2024
AbbVie is a Dividend King poised for growth. Gilead Sciences is a stable, low-risk candidate for investors.
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
07:30am, Friday, 28'th Jun 2024
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash
Final Trades: Keurig Dr Pepper, Gilead, BlackRock & JEPQ
01:24pm, Tuesday, 25'th Jun 2024
The Investment Committee discuss their top stocks to watch for the second half.
